According to the source material, because self-medication carries risks such as organ strain, drug-induced toxicities, and potential interactions, the following safety monitoring protocols and tests are recommended and documented during treatment with repurposed antiparasitics (such as fenbendazole, ivermectin, and mebendazole):
1. Routine Blood Panels & Organ Function Testing
Liver Function Tests (LFTs / Hepatic Panel):
Tracking liver enzymes (ALT, AST, bilirubin, and alkaline phosphatase) is essential.
Unmonitored self-treatment carries a risk of liver toxicity and elevated enzymes (transaminitis).
Case reports note that transient liver enzyme spikes can occasionally occur during therapy (sometimes reflecting metabolic stress or tumor lysis rather than direct drug-induced hepatotoxicity), making serial blood panels crucial to ensure levels normalize and avoid organ injury.


